{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifc4fkrbj3psmnsso32jgzxm32xmecrp6s3qixgubfchmfjxezwee",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3miickxsjd6g2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreib7n7rw2cblaaeyfbxcrxdq3t26nm6slo6jfbu3jrjca4ay5mk3aa"
    },
    "mimeType": "image/jpeg",
    "size": 54868
  },
  "path": "/2026/04/01/eli-lilly-obesity-pill-approved-orforglipron-foundayo/?utm_campaign=rss",
  "publishedAt": "2026-04-01T15:46:11.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Breaking News",
    "Pharma",
    "biotechnology",
    "Eli Lilly",
    "Novo Nordisk",
    "Obesity",
    "Pharmaceuticals",
    "weight loss"
  ],
  "textContent": "Eli Lilly’s obesity pill was approved by the FDA, setting it up for fierce competition against Novo Nordisk’s new Wegovy pill.",
  "title": "Eli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk",
  "updatedAt": "2026-04-01T20:57:57.000Z"
}